<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/7-836"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/7-836/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_7_836">
        <akn:num>7-836</akn:num>
        <akn:heading>Committee on Metabolic Disorders — Duties.</akn:heading>
<akn:subsection eId="subsec_7-836_1">
      <akn:num>(1)</akn:num>
      <akn:content><akn:p>Gather and disseminate information to further the public’s understanding of metabolic disorders;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_2">
      <akn:num>(2)</akn:num>
      <akn:content><akn:p>Consult the public, especially committees and groups of persons particularly affected by metabolic disorder programs;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_3">
      <akn:num>(3)</akn:num>
      <akn:content><akn:p>Make available to the public information on the operation of all programs on metabolic disorders within the District of Columbia, except for confidential information;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_4">
      <akn:num>(4)</akn:num>
      <akn:content><akn:p>Reevaluate on a continuing basis the need for and efficacy of newborn screening tests for galactosemia, homocystinuria, hypothyroidism, maple syrup urine disease, PKU, and sickle hemoglobinopathy;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_5">
      <akn:num>(5)</akn:num>
      <akn:content><akn:p>Recommend to the Mayor any additional screening tests for metabolic disorders that should be added to those required under § 7-833(a);</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_6">
      <akn:num>(6)</akn:num>
      <akn:content><akn:p>Recommend to the Mayor any screening tests for metabolic disorders required under § 7-833(a) that should be deleted;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_7">
      <akn:num>(7)</akn:num>
      <akn:content><akn:p>Consider the incidence of each metabolic disorder and the cost of detection and management of each metabolic disorder, and, where appropriate, consult District of Columbia and national experts concerning the medical, psychological, ethical, social and economic effects of programs for the detection and management of metabolic disorders;</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_8">
      <akn:num>(8)</akn:num>
      <akn:content><akn:p>Keep the Mayor informed as to new and improved techniques for screening and testing newborns for metabolic disorders; and</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_7-836_9">
      <akn:num>(9)</akn:num>
      <akn:content><akn:p>Recommend to the Mayor a laboratory or laboratories for designation under § 7-833(b).</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
